No Detail Found!

Inhibitory effect of AG490 on Stat3 Signal Transduction Pathway in Nasopharyngeal Carcinoma Cells.

Author(s)
Kai Li Department of ENT, Xi'an Ninth Hospital, Xi'an, China
Han Bao Department of ENT, Xi'an Ninth Hospital, Xi'an, China
Panying Zhang Department of ENT, Xi'an Ninth Hospital, Xi'an, China
Li Chen Department of ENT, Xi'an Ninth Hospital, Xi'an, China
Abstract
Objective: To determine the effect of JAK kinase inhibitor AG490 on proliferation and apoptosis of nasopharyngeal carcinoma cell line C666-1 and explore the inhibitory effect of AG490 on STAT3 signal transduction pathway. Study Design: An experimental study. Place and Duration of Study: Xi'an Ninth Hospital, Xi'an, China, from May 2015 to December 2016. Methodology: AG490 was applied to C666-1 cells. Cell proliferation was detected by MTT assay. Cell cycle and apoptosis were detected by flow cytometry. The expression of STAT3 and p-STAT3 protein was detected by immobilized Western blot. Results: AG490 could effectively inhibit proliferation of C666-1 cells in vitro, and the inhibitory effect was characterized by time and concentration dependence. AG490 induced apoptosis of nasopharyngeal carcinoma cells, and apoptosis rate increased with prolongation of the time. AG490 could inhibit expression of STAT3 and p-STAT3 protein in C666-1 cells. Conclusion: AG490 can down-regulate expression of STAT3 and p-STAT3 protein in C666-1 cells, inhibit proliferation of nasopharyngeal carcinoma cells and promote apoptosis of nasopharyngeal carcinoma cells.
Publication Details
Page(s) 699-702
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 11, Year: 2017

Request the full text from PASTIC

Keywords
JAK kinase inhibitor. Nasopharyngeal carcinoma. Signal transduction and transcriptional activation 3. Cell proliferation. Apoptosis.
References
LeeC,LimHK,Sakong , J,LeeYS,KimJ R,BaekSH,Janus, 2006.-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production,Mol Pharmacol 3 1041 -7
LiuY,WangL,WuY,LvC,LiX,CaoX, 2013.Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway,Toxicology 3 120 -31
LavecchiaA,DiGC,NovellinoE., 2011.STAT-3 inhibitors: state of the art and new horizons for cancer treatment,Curr Med Chem 16 2359 -75
KwakHB,SunHM,HaH,LeeJH,KimHN,LeeZH, 2008.AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways,Mol Cells 5 436 -42
WakeMS,WatsonCJ, 2015.STAT3 the oncogene-still eluding therapy?,FEBS J 14 2600 -11
SchroederA,HerrmannA,CherryholmesG,KowolikC,BuettnerR,PalS, 2014.Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling,Cancer Res 4 1227 -37
LeeJH,KimC,KimSH,SethiG,AhnKS, 2015.Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway,Cancer Lett 2 280 -93
OpdamFJM,KampM,BruijnRD,RoosE, 2004.Jak kinase activity is required for lymphoma invasion and metastasis,Oncogene 39 6647 -53
ChenH,CaoJ,HuangKJ,FangZ,TaoJ,LinZ, 2006.Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro,Cancer Sci 12 1417 -23
Chamorro, 2005.A. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway,J Neurochem 3 505 -18
JoungYH,NaYM,YooYB,DarvinP,SpN,KangDY, 2014.Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway,Int J Oncol 3 883 -95
KobayashiA,TanizakiY,KimuraA,IshidaY,NosakaM,ToujimaS, 2015.AG490, a Jak2 inhibitor, suppressed the progression of murine ovarian cancer,Eur J Pharmacol 766 63 -75
QianC,WangJ,YaoJ,WangL,XueM,LiuW, 2013.Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells,Anat Rec (Hoboken) 1865 -73
LiuSJ,CaiZW,LiuYJ,DongMY,SunLQ,HuGF, 2004.Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies,World J Gastroenterol 9 1246 -9
SavellJ,MaY,MorrowKS,JoveR,OlashawN,MoseleyPL, 2004.AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1,Mol Cancer Ther 2 205 -13
BaekSH,LeeJH,KoJH,LeeH,NamD,LeeSG, 2016.Ginkgetin blocks constitutive STAT3 activation and induces apoptosis through Induction of SHP-1 and PTEN tyrosine phosphatases,Phytother Res 4 567 -76
WenZ,ZhongZ,Jr DJ, 1995.Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation,Cell 2 241 -50
SupasaiS,AimoL,AdamoAM,MackenzieGG,OteizaPI, 2017.Zinc deficiency affects the stat1/3 signaling pathways in part through redox-mediated mechanisms,Redox Biology 11 469 -81
ChengW,ZhangC,RenX,JiangY,HanS,LiuY, 2017.Bioinformatic analyses reveal a distinct notch activation induced by stat3 phosphorylation in the mesenchymal subtype of glioblastoma,J Neurosurg 1 249 -59
YangXL,ZhangCD,WuHY,WuYH,ZhangYN,QinMB, 2014.Effect of trichostatin a on cne2 nasopharyngeal carcinoma cells - genome-wide DNA methylation alteration,Asian Pac J Cancer Prev 11 4663 -70
LiL,ZhangY,FanY,SunK,SuX,DuZ, 2017.Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes,Epigenomics 2 1 -19
0

Citations

0

Downloads

79

Views